News

Net Loss of Elixir Capital reported to Rs 5.43 crore in the quarter ended March 2026 as against net loss of Rs 6.27 crore during the previous quarter ended March 2025. Sales reported to Rs -1.15 crore in the quarter ended March 2026 as against Rs 0.29 crore during the previous quarter ended March 2025.For the full year,net profit declined 67.52% to Rs 3.03 crore in the year ended March 2026 as against Rs 9.33 crore during the previous year ended March 2025. Sales declined 17.26% to Rs 33.74 crore in the year ended March 2026 as against Rs 40.78 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales-1.150.29 PL 33.7440.78 -17 OPM %845.22-3293.10 -18.8849.14 - PBDT-10.15-9.74 -4 5.8118.84 -69 PBT-10.31-10.00 -3 5.3218.34 -71 NP-5.43-6.27 13 3.039.33 -68 Powered by Capital Market - Live News

Elixir Capital announced that the Board of Directors of the Company at its meeting held on 29 May 2026, inter alia, have recommended the final dividend of Rs 1.25 per equity Share (i.e. 12.5%) , subject to the approval of the shareholders.

Elixir Capital will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Elixir Capital rose 356.82% to Rs 4.02 crore in the quarter ended December 2025 as against Rs 0.88 crore during the previous quarter ended December 2024. Sales rose 121.98% to Rs 13.23 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales13.235.96 122 OPM %55.7139.26 - PBDT7.191.90 278 PBT7.081.82 289 NP4.020.88 357 Powered by Capital Market - Live News

Elixir Capital will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News